Cerebrovascular and Systemic Diseases

Cerebrovascular and Systemic Diseases CME / CPD 

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 2 (CSD2) Topics Include:  Acute Stroke, Antihypertensive Medication Regimens, Stroke in Pregnant Women, Interpret Findings of CSF Analysis, Manage Atrial Fibrillation, and more.  

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Format:
Available in Audio format.

Course Topics

Highlights from the 2nd Annual Comprehensive Stroke and Cerebrovascular Update

Formulate strategies to decrease door-to-needle times in patients with stroke; Select appropriate tests for initial workup of patients with stroke; Differentiate a transient ischemic attack from a stroke; Choose appropriate patients to receive anticoagulation therapy following a stroke; Diagnose and treat venous system stroke.

Neurology of Systemic Disease 2017 Part 1

Manage atrial fibrillation based on the patient's underlying condition and other risk factors; Reduce the risk for stroke in patients with patent foramen ovale; Treat a patient with a serious electrical injury; Recognize and manage pituitary apoplexy; Distinguish between diabetic ketoacidosis and hyperosmolar states based on symptomatology.

Cerebrovascular Disease 2017 Part 1

Provide management for a patient with acute stroke; Distinguish stroke from conditions that mimic stroke; Select appropriate candidates for endovascular therapy among patients who have had an ischemic stroke; Evaluate a patient presenting with transient ischemic attack; Consider dual antiplatelet therapy for patients with transient ischemic attack.

Neurology of Systemic Disease 2017 Part 2

Explain why most trials of antidiabetes drugs before 2015 failed to show reduction in cardiovascular disease; Select patients with type 2 diabetes who would be likely to benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide drugs; Describe possible mechanisms of action of SGLT2 inhibitors that may contribute to improved cardiovascular outcomes; Compare long-term outcomes of bariatric surgery and intensive medical therapy for treating type 2 diabetes.

Cerebrovascular Disease 2017 Part 2

Design a program that allows and motivates patients with stroke to modify their risk factors; Prescribe appropriate antihypertensive medication regimens for patients with stroke; Explain the role of lipoprotein (a) in the etiology of stroke; Employ simple bedside tests to predict outcomes in patients with stroke; Recognize signs of cardioembolic etiology in a patient with stroke.

Neurology of Systemic Disease 2017 Part 3

Recognize neurologic manifestations in a patient with systemic lupus erythematosus; Use clinical history and neurophysiologic studies to diagnose neurologic ?findings in patients with connective tissue disorders and vasculitides; Select and interpret appropriate neuroautoantibody tests in patients with ?neurologic signs and symptoms; Manage neurologic complications that develop after hematopoietic cell transplantation; Diagnose and manage neurologic complications after solid organ transplantation.

Cerebrovascular Disease 2017 Part 3

Diagnose inherited and uncommon causes of stroke; Manage stroke in a pregnant woman; List common causes of arterial ischemic stroke in children; Create a screening and follow-up protocol for patients with unruptured intracranial aneurysms that is based on patient-related and lesion-specific factors; Recognize and manage common cerebrovascular malformations. Discuss the findings of recent trials evaluating ocrelizumab in patients with multiple sclerosis.

Neurology of Systemic Disease 2017 Part 4

Recognize common patterns of neurologic involvement in patients with lymphomas, leukemias, and paraproteinemias; Interpret findings of CSF analysis in patients with lymphomas, leukemias, and paraproteinemias; Treat a patient with polycystic kidney disease; Evaluate neurologic findings in patients on dialysis; Adopt strategies for transition of care identified by the National Transitions of Care Coalition.

Cerebrovascular Disease 2017 Part 4

Evaluate a patient with transient ischemic attack (TIA) or stroke; Create a comprehensive treatment protocol emphasizing maximal medical therapy after stroke; Recognize and manage early and late complications of stroke; Manage malignant infarction syndrome after stroke; Follow guidelines for settling disagreements between family members and providers of care for a critically ill patient.

Updates in Cerebrovascular Disease

Highlights from the 2nd Annual Comprehensive Stroke and Cerebrovascular Update

Formulate strategies to decrease door-to-needle times in patients with stroke; Select appropriate tests for initial workup of patients with stroke; Differentiate a transient ischemic attack from a stroke; Choose appropriate patients to receive anticoagulation therapy following a stroke; Diagnose and treat venous system stroke.

Neurology of Systemic Disease 2017 Part 1

Manage atrial fibrillation based on the patient's underlying condition and other risk factors; Reduce the risk for stroke in patients with patent foramen ovale; Treat a patient with a serious electrical injury; Recognize and manage pituitary apoplexy; Distinguish between diabetic ketoacidosis and hyperosmolar states based on symptomatology.

Cerebrovascular Disease 2017 Part 1

Provide management for a patient with acute stroke; Distinguish stroke from conditions that mimic stroke; Select appropriate candidates for endovascular therapy among patients who have had an ischemic stroke; Evaluate a patient presenting with transient ischemic attack; Consider dual antiplatelet therapy for patients with transient ischemic attack.

Neurology of Systemic Disease 2017 Part 2

Explain why most trials of antidiabetes drugs before 2015 failed to show reduction in cardiovascular disease; Select patients with type 2 diabetes who would be likely to benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide drugs; Describe possible mechanisms of action of SGLT2 inhibitors that may contribute to improved cardiovascular outcomes; Compare long-term outcomes of bariatric surgery and intensive medical therapy for treating type 2 diabetes.

Cerebrovascular Disease 2017 Part 2

Design a program that allows and motivates patients with stroke to modify their risk factors; Prescribe appropriate antihypertensive medication regimens for patients with stroke; Explain the role of lipoprotein (a) in the etiology of stroke; Employ simple bedside tests to predict outcomes in patients with stroke; Recognize signs of cardioembolic etiology in a patient with stroke.

Neurology of Systemic Disease 2017 Part 3

Recognize neurologic manifestations in a patient with systemic lupus erythematosus; Use clinical history and neurophysiologic studies to diagnose neurologic ?findings in patients with connective tissue disorders and vasculitides; Select and interpret appropriate neuroautoantibody tests in patients with ?neurologic signs and symptoms; Manage neurologic complications that develop after hematopoietic cell transplantation; Diagnose and manage neurologic complications after solid organ transplantation.

Cerebrovascular Disease 2017 Part 3

Diagnose inherited and uncommon causes of stroke; Manage stroke in a pregnant woman; List common causes of arterial ischemic stroke in children; Create a screening and follow-up protocol for patients with unruptured intracranial aneurysms that is based on patient-related and lesion-specific factors; Recognize and manage common cerebrovascular malformations. Discuss the findings of recent trials evaluating ocrelizumab in patients with multiple sclerosis.

Neurology of Systemic Disease 2017 Part 4

Recognize common patterns of neurologic involvement in patients with lymphomas, leukemias, and paraproteinemias; Interpret findings of CSF analysis in patients with lymphomas, leukemias, and paraproteinemias; Treat a patient with polycystic kidney disease; Evaluate neurologic findings in patients on dialysis; Adopt strategies for transition of care identified by the National Transitions of Care Coalition.

Cerebrovascular Disease 2017 Part 4

Evaluate a patient with transient ischemic attack (TIA) or stroke; Create a comprehensive treatment protocol emphasizing maximal medical therapy after stroke; Recognize and manage early and late complications of stroke; Manage malignant infarction syndrome after stroke; Follow guidelines for settling disagreements between family members and providers of care for a critically ill patient.

Updates in Cerebrovascular Disease

Highlights from the 2nd Annual Comprehensive Stroke and Cerebrovascular Update

Formulate strategies to decrease door-to-needle times in patients with stroke; Select appropriate tests for initial workup of patients with stroke; Differentiate a transient ischemic attack from a stroke; Choose appropriate patients to receive anticoagulation therapy following a stroke; Diagnose and treat venous system stroke.

Cerebrovascular Disease 2017 Part 1

Provide management for a patient with acute stroke; Distinguish stroke from conditions that mimic stroke; Select appropriate candidates for endovascular therapy among patients who have had an ischemic stroke; Evaluate a patient presenting with transient ischemic attack; Consider dual antiplatelet therapy for patients with transient ischemic attack.

Cerebrovascular Disease 2017 Part 2

Design a program that allows and motivates patients with stroke to modify their risk factors; Prescribe appropriate antihypertensive medication regimens for patients with stroke; Explain the role of lipoprotein (a) in the etiology of stroke; Employ simple bedside tests to predict outcomes in patients with stroke; Recognize signs of cardioembolic etiology in a patient with stroke.

Cerebrovascular Disease 2017 Part 3

Diagnose inherited and uncommon causes of stroke; Manage stroke in a pregnant woman; List common causes of arterial ischemic stroke in children; Create a screening and follow-up protocol for patients with unruptured intracranial aneurysms that is based on patient-related and lesion-specific factors; Recognize and manage common cerebrovascular malformations. Discuss the findings of recent trials evaluating ocrelizumab in patients with multiple sclerosis.

Cerebrovascular Disease 2017 Part 4

Evaluate a patient with transient ischemic attack (TIA) or stroke; Create a comprehensive treatment protocol emphasizing maximal medical therapy after stroke; Recognize and manage early and late complications of stroke; Manage malignant infarction syndrome after stroke; Follow guidelines for settling disagreements between family members and providers of care for a critically ill patient.

Neurology of Systemic Disease 2017 Part 1

Manage atrial fibrillation based on the patient's underlying condition and other risk factors; Reduce the risk for stroke in patients with patent foramen ovale; Treat a patient with a serious electrical injury; Recognize and manage pituitary apoplexy; Distinguish between diabetic ketoacidosis and hyperosmolar states based on symptomatology.

Neurology of Systemic Disease 2017 Part 2

Explain why most trials of antidiabetes drugs before 2015 failed to show reduction in cardiovascular disease; Select patients with type 2 diabetes who would be likely to benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide drugs; Describe possible mechanisms of action of SGLT2 inhibitors that may contribute to improved cardiovascular outcomes; Compare long-term outcomes of bariatric surgery and intensive medical therapy for treating type 2 diabetes.

Neurology of Systemic Disease 2017 Part 3

Recognize neurologic manifestations in a patient with systemic lupus erythematosus; Use clinical history and neurophysiologic studies to diagnose neurologic ?findings in patients with connective tissue disorders and vasculitides; Select and interpret appropriate neuroautoantibody tests in patients with ?neurologic signs and symptoms; Manage neurologic complications that develop after hematopoietic cell transplantation; Diagnose and manage neurologic complications after solid organ transplantation.

Neurology of Systemic Disease 2017 Part 4

Recognize common patterns of neurologic involvement in patients with lymphomas, leukemias, and paraproteinemias; Interpret findings of CSF analysis in patients with lymphomas, leukemias, and paraproteinemias; Treat a patient with polycystic kidney disease; Evaluate neurologic findings in patients on dialysis; Adopt strategies for transition of care identified by the National Transitions of Care Coalition.

Updates in Cerebrovascular Disease

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Cardiology, Pulmonary Medicine, Neurology, Muscle & Movement Disorders, Family Practice, Internal Medicine, Obesity, and Nutrition 

If you have taken the current Cerebrovascular and Systemic Diseases CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.